A Study to Evaluate the Emollient Performance of Doublebase Once in the Treatment of Atopic Eczema

Ki vehet részt

• ii) Patients with atopic eczema (personal history or combined personal and familial atopy), of any severity in accordance with the NICE categorisation set out in the table below
• Baseline SCORAD assessment score of at least 15. iv) Patients or their parents/ legal guardians must be able to read and understand the patient information sheet and sign the Consent Form/Assent Form
• Patients normally managing their eczema by regular and ongoing use of leave-on emollient(s)
• Patients who are not currently using systemic or topically applied antibiotics or Doublebase Once
• Patients who are willing to use Doublebase Once, once daily, as their only leave-on emollient, for 4 weeks
• Patients who are willing to continue to use their standard cleansing regime and/or Doublebase Once as a soap substitute for the duration of the study; Additional inclusion criterion for subgroup for skin hydration assessments:
• Baseline corneometry measurement of ≤40 arbitrary units

Ki nem vehet részt

• Are currently using or have used in the previous month, any systemic or topically applied antibiotics or Doublebase Once for their atopic eczema
• Currently participating in any other ongoing research studies or have participated in a study in the previous 30 days
• Have a known history of intolerance or skin sensitivity to any of the ingredients of Doublebase Once (as identified on the patient information sheet and product labelling), or similar products
• Patients with any medical condition which, in the opinion of the Investigator, may adversely influence their ability to participate in the study
• Patients, or their parents/ legal guardians, who may have difficulties completing the questionnaire, which will be written in English only
• Employees of the Sponsor or Investigators, or any immediate family member (partner, offspring, parents, siblings, or sibling's offspring) of such employees